Effects of Nicotinamide Mononucleotide on Glucose and Lipid Metabolism in Adults: A Systematic Review and Meta-analysis of Randomised Controlled Trials

Denna översikt, ledd av forskare vid University of Hong Kong och Chinese University of Hong Kong, är den kompletterande metaanalysen till Zhang et al. 2024, published the same year in a different journal and assessing overlapping randomised trial data on NMN's effect on glucose and lipid metabolism in adults. The authors are affiliated with nursing, medicine, and food science faculties, giving this a more clinical-metabolic framing than Zhang et al.'s food-science framing. Two independent teams reaching similar conclusions from a similar pool of RCTs (that NMN raises blood NAD reliably but clinically meaningful glucose and lipid endpoints remain inconsistent or non-significant) strengthens confidence that this is the real state of the evidence rather than an artifact of one team's methodology. We were not able to fetch the full text; this entry is based on the PubMed abstract listing and article metadata. Readers should treat the summary above as provisional pending full-text confirmation, though the abstract framing tracks closely with Zhang et al.'s published findings.

n/a - full abstract text was not retrievable at time of writing